Presentation is loading. Please wait.

Presentation is loading. Please wait.

Suppression of plasma neutrophil elastase–α1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia 

Published byAugusta Short Modified over 5 years ago

Similar presentations

Presentation on theme: "Suppression of plasma neutrophil elastase–α1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia "— Presentation transcript:

1 Suppression of plasma neutrophil elastase–α1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia  Anthony Papagiannis, MRCP(UK)a, Ian A. Campbell, FRCPb, Dennis J. Shale, FRCPb  Journal of Allergy and Clinical Immunology  Volume 100, Issue 4, Pages (October 1997) DOI: /S (97) Copyright © 1997 Mosby, Inc. Terms and Conditions

2 Fig. 1 Serial changes in NEAPC levels (in nanograms per milliliter) and serum immunoglobulin levels (in grams per liter). Arrows indicate dates of intravenous immunoglobulin infusion. The horizontal line to the left side of the y axis represents the upper 95% CI for NEAPC in normal control subjects, and the dotted-and-dashed line to the right side of the y axis indicates the lower normal level for serum IgG. Journal of Allergy and Clinical Immunology  , DOI: ( /S (97) ) Copyright © 1997 Mosby, Inc. Terms and Conditions

Download ppt "Suppression of plasma neutrophil elastase–α1-anti-proteinase complex by adequate replacement therapy in a patient with acquired hypogammaglobulinemia "

Similar presentations

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
Yvan Boutin, PhD, Jacques Hébert, MD 

Yvan Boutin, PhD, Jacques Hébert, MD 
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Pulmonary abnormalities in patients with primary hypogammaglobulinemia

Pulmonary abnormalities in patients with primary hypogammaglobulinemia
Shin-Ichi Nishikawa, MD, PhD 

Shin-Ichi Nishikawa, MD, PhD 
Ischemic colitis during asthma attack

Ischemic colitis during asthma attack
Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,
The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,

The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,
Journal of Allergy and Clinical Immunology

Journal of Allergy and Clinical Immunology
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,

Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses  Patrick M. Schlievert,
Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,
Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug- induced cutaneous eruptions  Nikhil Yawalkar, MD, Maithili Shrikhande,

Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug- induced cutaneous eruptions  Nikhil Yawalkar, MD, Maithili Shrikhande,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Fuad M. Baroody, MD, Se-Hoon Suh, MD, Robert M. Naclerio, MD 

Fuad M. Baroody, MD, Se-Hoon Suh, MD, Robert M. Naclerio, MD 
Practice Notes from the AAAI

Practice Notes from the AAAI
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,

Similar presentations

Ads by Google